KEGG   PATHWAY: pgig04650
Entry
pgig04650                   Pathway                                
Name
Natural killer cell mediated cytotoxicity - Pteropus vampyrus (Indian flying fox)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
pgig04650  Natural killer cell mediated cytotoxicity
pgig04650

Other DBs
GO: 0042267
Organism
Pteropus vampyrus (Indian flying fox) [GN:pgig]
Gene
120581990  LCK; tyrosine-protein kinase Lck isoform X1 [KO:K05856] [EC:2.7.10.2]
120582132  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
120582890  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
120583089  [KO:K06541]
120583821  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
120584179  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
120584194  [KO:K06463]
120584205  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
120584219  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
120584275  CD48; CD48 antigen isoform X1 [KO:K06479]
120584395  [KO:K06516]
120584403  ITGB2; integrin beta-2 [KO:K06464]
120584534  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
120584662  HRAS; GTPase HRas isoform X1 [KO:K02833]
120584964  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
120585069  NRAS; GTPase NRas isoform X1 [KO:K07828]
120585845  PIK3CD; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
120586545  [KO:K06541]
120589378  [KO:K07986]
120589513  SHC2; SHC-transforming protein 2 isoform X1 [KO:K17447]
120589528  [KO:K05414]
120589531  [KO:K05414]
120590385  PAK1; serine/threonine-protein kinase PAK 1 isoform X1 [KO:K04409] [EC:2.7.11.1]
120591098  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
120591718  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
120592211  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
120592414  [KO:K07992]
120592415  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
120592785  [KO:K06541]
120592786  [KO:K06541]
120592787  [KO:K06541]
120594118  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
120594126  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
120594548  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
120596278  NCR2; LOW QUALITY PROTEIN: natural cytotoxicity triggering receptor 2 [KO:K06742]
120596960  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
120596984  PIK3CA; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
120598050  [KO:K07986]
120598334  NCR1; natural cytotoxicity triggering receptor 1 isoform X1 [KO:K06741]
120598793  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
120598794  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
120598866  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
120600054  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
120600272  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
120600327  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
120600384  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
120601203  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
120603037  [KO:K06516]
120603668  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
120603824  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
120604392  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
120604448  SOS2; son of sevenless homolog 2 [KO:K03099]
120604492  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
120604831  IFNG; interferon gamma [KO:K04687]
120605312  [KO:K05414]
120605473  IFNB1; interferon beta [KO:K05415]
120605533  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
120606426  [KO:K05414]
120606436  [KO:K07986]
120606549  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
120606631  PPP3CC; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
120606644  [KO:K04722]
120606646  [KO:K04722]
120606707  PTPN11; tyrosine-protein phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
120606851  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
120607034  [KO:K06516]
120607361  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
120608247  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
120608540  [KO:K01353] [EC:3.4.21.79]
120608541  [KO:K01353] [EC:3.4.21.79]
120608606  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
120609345  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
120609494  PRF1; LOW QUALITY PROTEIN: perforin-1 [KO:K07818]
120609542  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
120610234  [KO:K07360] [EC:2.7.10.2]
120610878  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
120611025  [KO:K06516]
120611673  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
120611725  [KO:K06516]
120612218  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
120613198  PTK2B; protein-tyrosine kinase 2-beta [KO:K05871] [EC:2.7.10.2]
120614076  [KO:K07293] [EC:3.1.3.48]
120614215  [KO:K06516]
120614216  [KO:K06516]
120614724  LCP2; lymphocyte cytosolic protein 2 isoform X1 [KO:K07361]
120614848  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
120615382  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
120615458  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
120615773  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
120616484  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
120616524  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
120616613  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
120616839  [KO:K07986]
120617124  [KO:K05414]
120617668  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
120617704  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
120618063  [KO:K06541]
120618064  [KO:K06516]
120618065  [KO:K06541]
120618066  [KO:K06541]
120618067  [KO:K06541]
120618068  [KO:K06541]
120618069  [KO:K06728]
120618074  [KO:K06516]
120618351  KRAS; GTPase KRas isoform X1 [KO:K07827]
120618435  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
120618875  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
120618939  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
120618944  TNF; tumor necrosis factor [KO:K03156]
120620083  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
120620121  MAPK3; LOW QUALITY PROTEIN: mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
120620147  LAT; linker for activation of T-cells family member 1 [KO:K07362]
120620206  [KO:K02649]
120621476  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
120621751  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
120622672  SHC4; SHC-transforming protein 4 [KO:K17449]
120622970  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
pgig04010  MAPK signaling pathway
pgig04020  Calcium signaling pathway
pgig04060  Cytokine-cytokine receptor interaction
pgig04210  Apoptosis
pgig04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system